1-4 of 4
Khê Hoang-Xuan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Feasibility of Repeated and Transient Blood–Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma

Ahmed Idbaih, Michael Canney, Lisa Belin, Carole Desseaux, Alexandre Vignot, Guillaume Bouchoux, Nicolas Asquier, Bruno Law-Ye, Delphine Leclercq, Anne Bissery, Yann De Rycke, Clementine Trosch, Laurent Capelle, Marc Sanson, Khe Hoang-Xuan, Caroline Dehais, Caroline Houillier, Florence Laigle-Donadey, Bertrand Mathon, Arthur André, Cyril Lafon, Jean-Yves Chapelon, Jean-Yves Delattre, Alexandre Carpentier
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (13): 3793–3801.
https://doi.org/10.1158/1078-0432.CCR-18-3643
Published: 01 July 2019
View article titled, Safety and Feasibility of Repeated and Transient Blood–Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma
Open the PDF for Safety and Feasibility of Repeated and Transient Blood–Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma in another window
Includes: Supplementary data
Journal Articles

Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas

Maite Verreault, Charlotte Schmitt, Lauriane Goldwirt, Kristine Pelton, Samer Haidar, Camille Levasseur, Jeremy Guehennec, David Knoff, Marianne Labussière, Yannick Marie, Azra H. Ligon, Karima Mokhtari, Khê Hoang-Xuan, Marc Sanson, Brian M. Alexander, Patrick Y. Wen, Jean-Yves Delattre, Keith L. Ligon, Ahmed Idbaih
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (5): 1185–1196.
https://doi.org/10.1158/1078-0432.CCR-15-1015
Published: 29 February 2016
View article titled, Preclinical Efficacy of the MDM2 Inhibitor RG7112 in <em>MDM2</em>-Amplified and <em>TP53</em> Wild-type Glioblastomas
Open the PDF for Preclinical Efficacy of the MDM2 Inhibitor RG7112 in <em>MDM2</em>-Amplified and <em>TP53</em> Wild-type Glioblastomas in another window
Includes: Supplementary data
Journal Articles

Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas

Alberto Gonzalez-Aguilar, Ahmed Idbaih, Blandine Boisselier, Naïma Habbita, Marta Rossetto, Alice Laurenge, Aurélie Bruno, Anne Jouvet, Marc Polivka, Clovis Adam, Dominique Figarella-Branger, Catherine Miquel, Anne Vital, Hervé Ghesquières, Rémy Gressin, Vincent Delwail, Luc Taillandier, Olivier Chinot, Pierre Soubeyran, Emmanuel Gyan, Sylvain Choquet, Caroline Houillier, Carole Soussain, Marie-Laure Tanguy, Yannick Marie, Karima Mokhtari, Khê Hoang-Xuan
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (19): 5203–5211.
https://doi.org/10.1158/1078-0432.CCR-12-0845
Published: 30 September 2012
View article titled, Recurrent Mutations of <em>MYD88</em> and <em>TBL1XR1</em> in Primary Central Nervous System Lymphomas
Open the PDF for Recurrent Mutations of <em>MYD88</em> and <em>TBL1XR1</em> in Primary Central Nervous System Lymphomas in another window
Includes: Supplementary data
Journal Articles

Genetic Risk Profiles Identify Different Molecular Etiologies for Glioma

Matthias Simon, Fay J. Hosking, Yannick Marie, Konstantinos Gousias, Blandine Boisselier, Catherine Carpentier, Johannes Schramm, Karima Mokhtari, Khe Hoang-Xuan, Ahmed Idbaih, Jean-Yves Delattre, Mark Lathrop, Lindsay B. Robertson, Richard S. Houlston, Marc Sanson
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (21): 5252–5259.
https://doi.org/10.1158/1078-0432.CCR-10-1502
Published: 31 October 2010
View article titled, Genetic Risk Profiles Identify Different Molecular Etiologies for Glioma
Open the PDF for Genetic Risk Profiles Identify Different Molecular Etiologies for Glioma in another window